{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-bioanalytical-testing-and-result-reporting”
},
“headline”: “SOP for Bioanalytical Testing and Result Reporting”,
“description”: “This SOP defines standardized procedures for conducting bioanalytical testing and reporting results in clinical trials, ensuring compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements. It includes assay validation, sample preparation, data review, reporting, and archiving.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Bioanalytical Testing and Result Reporting

Purpose

The purpose of this SOP is to outline standardized, regulatory-compliant procedures for performing bioanalytical testing and reporting results from clinical trial samples. This ensures reliability of pharmacokinetic (PK), pharmacodynamic (PD), and biomarker data while maintaining data integrity for regulatory submissions.

Scope

This SOP applies to all laboratory staff, CROs, and sponsors involved in the analysis of clinical trial biological samples. It covers sample preparation, assay validation, instrument operation, calibration curve generation, QC sample monitoring, data review, reporting, deviations, and record archiving.

Responsibilities

• Bioanalytical Laboratory: Conducts testing, validates assays, and reports results.
• Laboratory Analysts: Perform sample preparation, testing, and documentation.
• QA: Audits laboratory compliance with GLP, GCP, and regulatory standards.
• Sponsor: Reviews and approves bioanalytical reports for regulatory submission.
• CRA: Verifies laboratory compliance during monitoring visits.

Accountability

The Bioanalytical Laboratory Head is accountable for assay accuracy, result reporting, and compliance with global regulatory requirements. The Sponsor is accountable for ensuring oversight and submission readiness.

Procedure

1. Sample Receipt
1.1 Verify chain of custody upon receipt of samples.
1.2 Record details in Sample Receipt Log (Annexure-1).
1.3 Store samples in validated freezers until analysis.

2. Method Validation
2.1 Validate all analytical methods before use in clinical trials.
2.2 Parameters include accuracy, precision, linearity, selectivity, sensitivity, stability, and recovery.
2.3 Maintain Method Validation Report in laboratory files.

3. Sample Preparation
3.1 Thaw samples at controlled temperature.
3.2 Process according to validated SOPs (protein precipitation, liquid-liquid extraction, SPE).
3.3 Record preparation details in Sample Preparation Log (Annexure-2).

4. Instrument Operation
4.1 Use validated instruments such as LC-MS/MS.
4.2 Calibrate daily and record in Equipment Calibration Log (Annexure-3).
4.3 Maintain instrument audit trails.

5. Calibration Curve and QC Samples
5.1 Generate calibration curve with at least 6–8 concentration points.
5.2 Include low, medium, and high QC samples in each run.
5.3 Results must be within ±15% of nominal values (±20% for LLOQ).

6. Data Review and Reporting
6.1 Analysts review raw data and generate run summary.
6.2 QA verifies accuracy and completeness.
6.3 Prepare Bioanalytical Report (Annexure-4).
6.4 Report results to Sponsor within timelines defined in protocol.

7. Repeat Analysis
7.1 Repeat analysis only if justified (e.g., sample integrity issue).
7.2 Document reason and obtain QA approval.

8. Deviations
8.1 Record deviations in Bioanalytical Deviation Log (Annexure-5).
8.2 Initiate CAPA for major deviations.

9. Archiving
9.1 Archive raw data, calibration curves, chromatograms, and reports in laboratory archives.
9.2 Retain documents as per regulatory timelines.

Abbreviations

• SOP: Standard Operating Procedure
• PK: Pharmacokinetic
• PD: Pharmacodynamic
• QA: Quality Assurance
• CRO: Contract Research Organization
• LC-MS/MS: Liquid Chromatography–Tandem Mass Spectrometry
• LLOQ: Lower Limit of Quantitation
• CAPA: Corrective and Preventive Action
• GLP: Good Laboratory Practice

Documents

1. Sample Receipt Log (Annexure-1)
2. Sample Preparation Log (Annexure-2)
3. Equipment Calibration Log (Annexure-3)
4. Bioanalytical Report (Annexure-4)
5. Bioanalytical Deviation Log (Annexure-5)

References

• ICH M10 – Bioanalytical Method Validation
• FDA – Bioanalytical Method Validation Guidance
• EMA – Guideline on Bioanalytical Method Validation
• CDSCO – Laboratory Standards for Clinical Trials
• WHO – Good Laboratory Practice in Bioanalysis

Version: 1.0

Approval Section

Annexures

Annexure-1: Sample Receipt Log

Annexure-2: Sample Preparation Log

Annexure-3: Equipment Calibration Log

Annexure-4: Bioanalytical Report

Annexure-5: Bioanalytical Deviation Log

Revision History

For more SOPs visit: Pharma SOP